We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Enhertu
Australian Public Assessment Report
Device/Product Name
Enhertu
Active ingredients
Trastuzumab deruxtecan
AusPAR Date
Published
Sponsor
Submission Number
Type C- PM-2022-02867-1-4
Submission Type
Extension of indications
Decision
Approved